4 COMPLETE remissions and AF asks Is this real?
Insmeds was BS this one too. Cramers a clown
"We just got a first look at results from a Mayo Clinic study of Geron's (GERN_) imetelstat in myelofibrosis. The stock is soaring, up 98% to $7.15 in early trading.
The headline: 4 patients had complete remission (CR), 1 patient had a partial remission (PR) and 3 patients showed clinical improvement (CI). This is out of 18 patients evaluable for response -- 11 from the first Cohort A and 7 from Cohort B. But (uh oh) are these imetelstat CRs and PRs real?